improvements in building in vitro pluripotent stem cell-derived disease models
Published 5 years ago • 121 plays • Length 27:45Download video MP4
Download video MP3
Similar videos
-
27:45
improvements in building in vitro pluripotent stem cell-derived disease models
-
46:12
selecting the right tools to build your pluripotent stem cell based disease models
-
49:19
kile mangan & tk feaster - advances in modeling human diseases using induced pluripotent stem cell-d
-
23:59
disease modelling with human pluripotent stem cells: general principles
-
48:52
engineering stem cell biology for disease modelling and therapeutics
-
2:22
making pluripotent stem cells
-
1:13:24
tools & strategies for implementing ipsc-based cell models for neurodegenerative disease drug dis...
-
25:05
generation of induced pluripotent stem cell-derived cardiomyocytes for disease modeling
-
7:36
the rise and fall of stem cell research
-
15:59
regenerate stem cells with food and lifestyle
-
56:20
modeling kidney disease and regeneration with organoids derived from human pluripotent stem cells
-
46:12
selecting the right tools to build your pluripotent stem cell based disease models
-
30:29
optimizing stem cells workflows to build better disease models
-
44:42
disease modeling therapies retinal ciliopathies using patient pluripotent stem cell derived organoid
-
23:59
disease modelling with human pluripotent stem cells: principles and specific applications to obesity
-
1:06:10
modeling the human brain using induced pluripotent stem cells ipscs 1
-
23:18
manufacturing of induced pluripotent stem cells and immune-derived cells
-
49:26
harnessing ipsc-derived cardiac progenitor cells and fibroblasts for myocardial repair
-
35:21
sps 2018: implementing human ipsc-derived cells in early safety assessment & disease modeling
-
2:01
in vitro differentiation of stem cells into cardiomyocyte like cells | protocol preview
-
17:56
induced pluripotent stem cell-derived oligodendrocyte progenitor cells in secondary ms - sae komatsu
-
1:17:21
investigative in vitro drug toxicology with human ipsc derived cardiomyocytes